Physician profile
Thomas S Sellner
NPI 1891953956
$3,474.97
in general payments reported to CMS, 2019-2025
16 companies · $635 in 2025
The $635 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $180 · 2021: $558 · 2022: $700 · 2023: $444 · 2024: $648 · 2025: $635.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,693 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,692.93 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $832.55 | 2019-2023 | Trudi Nav Cable |
| Genzyme Corporation | $657.68 | 2019-2025 | |
| Neurent Medical Limited | $522.40 | 2022-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Glaxosmithkline, LLC. | $403.22 | 2022-2025 | Nucala |
| Aerin Medical INC. | $377.93 | 2019-2023 | |
| 3nt Medical | $122.85 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $92.32 | 2021-2024 | Dupixent |
| Intersect Ent, INC. | $91.93 | 2019-2021 | |
| Amgen INC. | $85.04 | 2025 | Tezspire |
| Integra Lifesciences Corporation | $83.23 | 2024-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Optinose US, INC. | $63.97 | 2019-2022 | |
| Inspire Medical Systems, INC. | $55.48 | 2023-2024 | Inspire |
| Stryker Corporation | $27.38 | 2025 | Scopis Ent |
| Medtronic, INC. | $24.42 | 2025 | Stealthstation S8 Platform |
| Astrazeneca Pharmaceuticals LP | $18.67 | 2025 | Tezspire |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $15.90 | 2024 | Ryaltris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Sellner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.